VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
11 hedge funds and large institutions have $22.1M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2015 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
Holders
11
Holders Change
–
Holders Change %
0%
% of All Funds
0.29%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
2
Increased
1
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
PA
1
Perceptive Advisors
New York
|
$6.79M |
2 |
TFCP
2
Twin Focus Capital Partners
Boston,
Massachusetts
|
$43K |
3 |
3
UBS Group
Zurich,
Switzerland
|
$2K |
Top Sellers
1 |
1
Hudson Bay Capital Management
Stamford,
Connecticut
|
$2.13M |
2 |
2
Goldman Sachs
New York
|
$0 |
3 |
VKH
3
Virtu KCG Holdings
New York
|
$0 |
4 |
TRCT
4
Tower Research Capital (TRC)
New York
|
$2K |